index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Cachexia DHPR α1S Inbred C57BL Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Knockout Muscles/physiopathology LncRNA Delivery Duchenne muscular dystrophy DMD Animal/physiopathology Humans L-Type DMD MiARN Inbred mdx Gene modifiers Molecular Sequence Data Base Sequence NNOS Dystrophin Liver Calcium Gene Expression Regulation/drug effects Metabolism MES Cell homeostasis Energy Metabolism/drug effects Dystrophin-EGFP Autophagy Mice Dystrophie Musculaire de Becker BMD Becker muscular dystrophy BMD Mdx mouse Cultured Becker muscular dystrophy CaV subunits Diseases Long noncoding RNA Clinical trials Génomique Calcium Channels Dynamin 2 Immunoglobulin Fc Fragments/pharmacology Hear Cells Duchenne muscular dystrophy Ex-vivo NAD+ Dystrophie musculaire de Becker Homeostasis Activin Receptors Centronuclear myopathy LncARN CaVβs Long QT Becker BMD muscular dystrophy Muscular dystrophy Duchenne DMD dystrophy Molecular docking Multi exon skipping Hepatocellular carcinoma Cardiomyopathy Exon skipping Male Cell Line Human Umbilical Vein Endothelial Cells Muscle Biology Muscular Dystrophy CD38 Multi resolution modeling Gene expression Cardiomyopathie Antisense oligonucleotides Skeletal muscle Dystrophy Muscle Strength BMD Modificateurs de gènes Dystrophie Musculaire de Duchenne DMD Multiresolution modeling Genomic Muscle development Muscle Morphogenesis DMO CTNNB1 Muscular Atrophy Myogenesis Cell Biology LKB1 Dystrophin central domain Animals Dystrophine Allele‐specific silencing therapy Drp1 Epigenetics Inhibitors Myotendinous junction Mitochondrial fission Invivo